Inside informationEnglish
AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 17/06/2026, 18:04
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 118314_20260617